Clinical Infectious Diseases · 2005 · 76 citations · 5 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial PharmacotherapyAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceBeta-lactam ResistanceCarbapenem ResistanceCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenem-hydrolyzing EnzymesCarbapenemase EnzymesEscherichia ColiEscherichia Coli ResistanceExtended-spectrum Beta-lactamase Producing OrganismsExtended-spectrum Beta-lactamase-producing Organisms
A 76-year-old woman had recurrent urosepsis due to extended-spectrum beta -lactamase-positive Escherichia coli. Imipenem resistance was detected after long-term imipenem-meropenem therapy. The carbapenem-hydrolyzing enzyme gene was identified as blaKPC-3. To our knowledge, this is the first documented case in which carbapenem-resistant E. coli emerged during therapy with imipenem and meropenem, and the first identification of the carbapenem-hydrolyzing enzyme in E. coli isolates.
5
Hesna Yigit, Anne Marie Queenan, Gregory J. Anderson et al. · Antimicrobial Agents and Chemotherapy · 2001 · 1.6K citations · Full text
Neil Woodford, Philip M. Tierno, Katherine Young et al. · Antimicrobial Agents and Chemotherapy · 2004 · 446 citations · Full text
Paul Stapleton, Kevin Shannon, G.L. French · Antimicrobial Agents and Chemotherapy · 1999 · 128 citations · Full text